Oruka Therapeutics (ORKA) Return on Invested Capital (2018 - 2020)
Oruka Therapeutics' quarterly Return on Invested Capital came in at 0.0% in Q4 2020, little changed year-on-year from 0.0% in Q1 2020, and down 4.32% quarter-over-quarter from 0.0% in Q3 2020.
Oruka Therapeutics has reported Return on Invested Capital for 3 years, with the latest figure at 0.0% in Q4 2020.
- For the quarter ending Q4 2020, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2020 stood at 0.0% (changed 0.0% YoY), and the FY2020 full-year result was 0.0%, changed 0.0% from the prior year.
- Return on Invested Capital for Q4 2020 stood at 0.0%, down from 0.0% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.0% in Q3 2019, with the low at 0.01% in Q4 2019.
- Average Return on Invested Capital over 3 years is 0.0%, with a median of 0.0% recorded in 2020.
- Year-over-year, Return on Invested Capital changed 0 bps in 2019 and declined 1 bps in 2020.
- Tracing ORKA's Return on Invested Capital over 3 years: stood at 0.0% in 2018, then plunged by 180 bps to 0.01% in 2019, then surged by 71 bps to 0.0% in 2020.
- The last three Return on Invested Capital figures came in at 0.0% (Q4 2020), 0.0% (Q3 2020), and 0.01% (Q2 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -0.01% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -0.01% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.01% |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | -0.01% |
| Dec 31, 2019 | -0.01% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 0.00% |